<DOC>
	<DOC>NCT00000353</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.</brief_summary>
	<brief_title>Trial of Buprenorphine/Naloxone for Opiate Dependence - 2</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine, Naloxone Drug Combination</mesh_term>
	<criteria>Please contact site for information.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>57 Years</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>opiate dependence</keyword>
</DOC>